ALGN vs. DXCM

In the year-to-date period, ALGN achieves a -11.63% return, which is significantly lower than DXCM's -8.99% return. Over the past 10 years, ALGN has underperformed DXCM with an annualized return of 12.17%, while DXCM has yielded a comparatively higher 15.45% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Align Technology, Inc. (ALGN) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ALGN Sharpe Ratio is -0.95, which is comparable to the DXCM Sharpe Ratio of -0.81. The chart below compares the historical Sharpe Ratios of ALGN and DXCM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither ALGN nor DXCM has paid dividends to shareholders.

The maximum ALGN drawdown since its inception was -92.80%, roughly equal to the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for ALGN and DXCM. For additional features, visit the drawdowns tool.

Align Technology, Inc. (ALGN) and DexCom, Inc. (DXCM) have volatilities of 18.54% and 17.73%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Align Technology, Inc. and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.